JP2020524524A5 - - Google Patents

Download PDF

Info

Publication number
JP2020524524A5
JP2020524524A5 JP2020516379A JP2020516379A JP2020524524A5 JP 2020524524 A5 JP2020524524 A5 JP 2020524524A5 JP 2020516379 A JP2020516379 A JP 2020516379A JP 2020516379 A JP2020516379 A JP 2020516379A JP 2020524524 A5 JP2020524524 A5 JP 2020524524A5
Authority
JP
Japan
Prior art keywords
cflar
hla
expression level
melanoma
normalized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020516379A
Other languages
English (en)
Japanese (ja)
Other versions
JP7227964B2 (ja
JP2020524524A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/033658 external-priority patent/WO2018217627A1/en
Publication of JP2020524524A publication Critical patent/JP2020524524A/ja
Publication of JP2020524524A5 publication Critical patent/JP2020524524A5/ja
Application granted granted Critical
Publication of JP7227964B2 publication Critical patent/JP7227964B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020516379A 2017-05-25 2018-05-21 黒色腫の検出方法 Active JP7227964B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762511058P 2017-05-25 2017-05-25
US62/511,058 2017-05-25
PCT/US2018/033658 WO2018217627A1 (en) 2017-05-25 2018-05-21 Methods for melanoma detection

Publications (3)

Publication Number Publication Date
JP2020524524A JP2020524524A (ja) 2020-08-20
JP2020524524A5 true JP2020524524A5 (https=) 2021-07-26
JP7227964B2 JP7227964B2 (ja) 2023-02-22

Family

ID=62620988

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020516379A Active JP7227964B2 (ja) 2017-05-25 2018-05-21 黒色腫の検出方法

Country Status (14)

Country Link
US (2) US20180340934A1 (https=)
EP (1) EP3631017B1 (https=)
JP (1) JP7227964B2 (https=)
KR (1) KR102763004B1 (https=)
CN (1) CN111315897B (https=)
AU (1) AU2018273844B2 (https=)
BR (1) BR112019024481A2 (https=)
CA (1) CA3064732A1 (https=)
DK (1) DK3631017T3 (https=)
ES (1) ES2920288T3 (https=)
IL (1) IL270787B2 (https=)
MX (1) MX2019014026A (https=)
PL (1) PL3631017T3 (https=)
WO (1) WO2018217627A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112019024481A2 (pt) 2017-05-25 2020-07-14 Liquid Biopsy Research LLC métodos para detecção de melanoma
CN114901819A (zh) 2019-10-10 2022-08-12 液体活检研究有限责任公司 用于生物样品和rna稳定化的组合物、方法和试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074430A2 (en) * 2005-01-07 2006-07-13 The Johins Hopkins University Biomarkers for melanoma
WO2008031041A2 (en) * 2006-09-07 2008-03-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Melanoma gene signature
JP2010508826A (ja) 2006-11-03 2010-03-25 ベイラー リサーチ インスティテュート 血中白血球マイクロアレイ分析を介した、転移性メラノーマの診断及び免疫抑制インディケーターのモニタリング
CA2668831A1 (en) * 2006-11-06 2008-06-12 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring and treatment of melanoma
US20110070582A1 (en) * 2008-11-03 2011-03-24 Source Precision Medicine, Inc. d/b/d Source MDX Gene Expression Profiling for Predicting the Response to Immunotherapy and/or the Survivability of Melanoma Subjects
EP2488874A4 (en) * 2009-10-13 2013-08-14 Univ Johns Hopkins BIOMARKERS FOR THE IDENTIFICATION OF MELANOMOTUM CELLS
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
EA201590041A1 (ru) * 2012-07-03 2015-04-30 Ратиофарм Гмбх Твердая форма холиновой соли вемурафениба
KR102762958B1 (ko) 2014-09-15 2025-02-04 클리프톤 라이프 사이언시즈 엘엘씨 위장관췌장 신경내분비 신생물의 진단을 위한 조성물, 방법 및 키트
BR112019024481A2 (pt) 2017-05-25 2020-07-14 Liquid Biopsy Research LLC métodos para detecção de melanoma

Similar Documents

Publication Publication Date Title
US20220396842A1 (en) Method for using gene expression to determine prognosis of prostate cancer
JP5415963B2 (ja) 新しい癌マーカー
JP7111630B2 (ja) 炎症性腸疾患用のバイオマーカー
US20180051343A1 (en) Thyroid cancer diagnosis by dna methylation analysis
JP2017528164A5 (https=)
JP2018524972A (ja) 肺癌の診断または検出のための方法及び組成物
JP2021514624A5 (https=)
JP2017060515A (ja) 遺伝子の発現を分析することによって患者における癌の転帰を予測するための方法
JP2024523848A (ja) 癌検出方法、キットおよびシステム
JP2021511057A5 (https=)
US20210277479A1 (en) Risk scores based on human phosphodiesterase 4 d variant 7 expression
CN107858434B (zh) lncRNA在肝癌诊断以及预后预测中的应用
CA2989480C (en) Kit and method for the diagnosis/prognosis of idiopathic scoliosis
JP2020528274A5 (https=)
JP7084034B2 (ja) 神経芽腫の微小残存病変を評価するために用いられる試薬、およびそれを用いた生体試料の分析方法
JP2020524524A5 (https=)
CN106550605B (zh) 用于预测心力衰竭和心肌梗塞患者中疾病进展的线粒体非编码rna
JP2019512212A (ja) 活動性結核を検出するための方法
HK1253908A1 (en) Method for the diagnosis/prognosis of adolescent idiopathic scoliosis
JP2017529094A5 (https=)
US20220372573A1 (en) Methods and systems for detection of kidney disease or disorder by gene expression analysis
IL317236A (en) Predicting peptide receptor radiotherapy using gene expression testing
CN111315897B (zh) 用于黑素瘤检测的方法
WO2017102902A1 (en) Micrornas as predictive biomarkers of type 1 diabetes
US20170130277A1 (en) Biomarker for colorectal cancer